Adrizzone 2006 |
Ineligible comparator group (AZA) |
Ahluwalia 1992 |
Not a randomized control trial |
Behrens 2013 |
No control group |
Dignass 2018 |
No control group (both groups received 1000 mg mesalamine a day) |
Fiorino 2019 |
The study drug was not pure 5‐ASA, but also contained sodium hyaluronate |
Gross 2011 |
Ineligible comparator group (Budesonide) |
Irvine 2008 |
Not a randomized control trial |
Kamm 2009 |
Not a randomized control trial |
Levine 2017 |
Not an oral 5‐ASA formulation |
Mahmood 2005 |
Not an oral 5‐ASA formulation |
Paoluzi 2002 |
No control group |
Park 2018 |
Maintenance study |
Pruitt 1991 |
Not a randomized control trial |
Rubin 2017 |
Compares once‐daily budesonide to placebo in people who are refractory to 5‐ASA treatment |
Safdi 1997 |
Not an oral 5‐ASA formulation |
Suzuki 2017 |
Not an induction trial |
Turner 2017 |
A pediatric study |
Vecchi 2001 |
Not an oral 5‐ASA formulation |
Vernia 2000 |
No control group |
Ye 2018 |
No control group (both groups received same oral regimen) |
Yoshimura 2018 |
No control group |